United States· US:76162-801_784ad93e-f3b9-48a8-beff-e2aae8b5e147

topcare mucus d

A medicinal product containing guaifenesin; pseudoephedrine hydrochloride, registered in United States by Topco Associates LLC.

US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedtopcare mucus dATC—REGISTER NO.US:76162-801_784ad93e…PACKS LISTED2CHECKEDSeptember 27, 2026

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE
Manufacturer
Topco Associates LLC
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    7616280189
    18 BLISTER PACK in 1 CARTON (76162-801-89) / 1 TABLET, MULTILAYER, EXTENDED RELEASE in 1 BLISTER PACK
  • ndc11
    76162-801-89

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Guaifenesin; pseudoephedrine hydrochloride in 3 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All guaifenesin; pseudoephedrine hydrochloride products

Authorised across Europe · EMA

The same active substance is authorised in 4 EEA countries. Names it is sold under:

  • Spain · Iniston Mucosidad Y Congestión, Respidina Expectorante Junior
  • United Kingdom (Northern Ireland) · Benylin Mucus Cough Plus Decongestant, Boots Cough And Decongestant 6 Years +
  • Ireland · Benylin Phlegm Cough Plus Decongestant, Robitussin Plus
  • Romania · Bioflu Expectorant

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/99b25e95-d11c-4827-a0ec-37e0274ee944
GET /v1/drugs/99b25e95-d11c-4827-a0ec-37e0274ee944?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "600; 60",
  "substance": "GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE",
  "productndc": "76162-801",
  "dosage_form": "TABLET, MULTILAYER, EXTENDED RELEASE",
  "dea_schedule": null,
  "strength_unit": "mg/1; mg/1",
  "application_number": "ANDA214407",
  "marketing_category": "ANDA"
}

See everything about guaifenesin; pseudoephedrine hydrochloride.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.